One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

Abstract Introduction This multicenter, longitudinal, observational real-world study evaluated the efficacy and safety of switching to intravitreal aflibercept 8 mg (Afl 8) in pretreated eyes with neovascular age-related macular degeneration (nAMD) within the Swiss Retina Research Network. A total o...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Alice M. Kitay, Anne Tillmann, Isabel Pfister, Christin Schild, Matteo Bonanata, Katharina Heck, Tahm Spitznagel, Felix Gabathuler, Nicolo Bartolomeo, Simon Magnin, Jordan Löliger, Marion R. Munk, Moreno Menghini, Katja Hatz, Gábor Márk Somfai, Sandrine Zweifel, Aude Ambresin, Chiara M. Eandi, Nicolas Feltgen, Andreas Weinberger, Justus G. Garweg, Malaika M. Kurz-Levin
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Adis, Springer Healthcare 2026-03-01
سلاسل:	Ophthalmology and Therapy
الموضوعات:	Aflibercept Anti-VEGF Switcher Age-related macular degeneration Retina Swiss Retina Research Network
الوصول للمادة أونلاين:	https://doi.org/10.1007/s40123-026-01344-x
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!